Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Protect NIH's DNA advisory committee.

Adelman ZN, Albritton LM, Boris-Lawrie K, Buchmeier MJ, Cannon P, Cho M, DiGiusto D, Donahue JK, Federoff HJ, Hammarskjold ML, Hardison AD, Hearing P, Lee B, Lee DA, Porteus MH, Ross LF, Ross SR, Wooley DP, Zoloth L.

Science. 2018 Oct 26;362(6413):409-410. doi: 10.1126/science.aav2483. No abstract available.

PMID:
30361364
2.

A directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line.

Wooley DP, Sharma P, Weinstein JR, Kotha Lakshmi Narayan P, Schaffer DV, Excoffon KJDA.

J Virol Methods. 2017 Dec;250:47-54. doi: 10.1016/j.jviromet.2017.09.008. Epub 2017 Sep 14.

3.
4.

Tangential flow ultrafiltration: a "green" method for the size selection and concentration of colloidal silver nanoparticles.

Anders CB, Baker JD, Stahler AC, Williams AJ, Sisco JN, Trefry JC, Wooley DP, Pavel Sizemore IE.

J Vis Exp. 2012 Oct 4;(68). pii: 4167. doi: 10.3791/4167.

5.

Rapid assessment of antiviral activity and cytotoxicity of silver nanoparticles using a novel application of the tetrazolium-based colorimetric assay.

Trefry JC, Wooley DP.

J Virol Methods. 2012 Jul;183(1):19-24. doi: 10.1016/j.jviromet.2012.03.014. Epub 2012 Mar 23.

PMID:
22465243
6.

Size selection and concentration of silver nanoparticles by tangential flow ultrafiltration for SERS-based biosensors.

Trefry JC, Monahan JL, Weaver KM, Meyerhoefer AJ, Markopolous MM, Arnold ZS, Wooley DP, Pavel IE.

J Am Chem Soc. 2010 Aug 18;132(32):10970-2. doi: 10.1021/ja103809c.

PMID:
20698645
7.

Is gene therapy a good therapeutic approach for HIV-positive patients?

Marathe JG, Wooley DP.

Genet Vaccines Ther. 2007 Feb 14;5:5.

8.

A new cell-based assay for measuring the forward mutation rate of HIV-1.

Huang KJ, Wooley DP.

J Virol Methods. 2005 Mar;124(1-2):95-104. Epub 2004 Dec 28.

PMID:
15664056
9.

Restricted entry of R5 HIV Type 1 strains into eosinophilic cells.

Taylor RJ, Schols D, Wooley DP.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1244-53.

PMID:
15588346
10.
11.

High fidelity of homologous retroviral recombination in cell culture.

Bircher LA, Rigano JC, Ponferrada VG, Wooley DP.

Arch Virol. 2002 Sep;147(9):1665-83.

PMID:
12209308
13.

Strain-dependent productive infection of a unique eosinophilic cell line by human immunodeficiency virus type 1.

Wooley DP, Peterson KT, Taylor RJ, Paul CC, Baumann MA.

AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1405-15.

PMID:
11018860
14.

Retroviral recombination is nonrandom and sequence dependent.

Wooley DP, Bircher LA, Smith RA.

Virology. 1998 Mar 30;243(1):229-34.

15.

Direct demonstration of retroviral recombination in a rhesus monkey.

Wooley DP, Smith RA, Czajak S, Desrosiers RC.

J Virol. 1997 Dec;71(12):9650-3.

16.

Significance of premature stop codons in env of simian immunodeficiency virus.

Kodama T, Wooley DP, Naidu YM, Kestler HW 3rd, Daniel MD, Li Y, Desrosiers RC.

J Virol. 1989 Nov;63(11):4709-14.

17.

Re: Angliss V.E. "Holte revisited--a review of the quality of prosthetic treatment".

Wooley DP.

Prosthet Orthot Int. 1987 Apr;11(1):46-7. No abstract available.

PMID:
3588265

Supplemental Content

Loading ...
Support Center